Leonard Sank Net Worth & Insider Trades

Leonard Sank - Director, Oramed Pharmaceuticals Inc

As of August 10, 2022

What is Leonard Sank's Net Worth?

The current estimated net worth of Oramed Pharmaceuticals Inc's Director, Leonard Sank, is estimated to be about $650.06K . Leonard Sank owns about 513,888 units of Oramed Pharmaceuticals Inc common stock. In the last 14 years at Oramed Pharmaceuticals Inc, Leonard Sank has sold an estimated value of $1.75M worth.

What is Leonard Sank's Past Insider Trading?

Leonard Sank's largest purchase order was 54,517 units , worth over $195.71K on July 18, 2019. In total, Leonard Sank has made about 20 transactions over 14 years of their time at Oramed Pharmaceuticals Inc. Leonard Sank usually trades in January, with the busiest year in 2008. The most recent transaction was a purchase order of 25,000 units , worth over $73K on September 11, 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Leonard Sank's' Mailing Address?

  • Mailing address is 3 Blair Road Cape Town T3 8005 South Africa

Oramed Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Nadav Kidron 2020 $439,076 $220,582 $569,062 $539,131 $1,767,851
Nadav Kidron 2019 $419,460 $224,975 $398,910 $507,750 $1,551,095
Nadav Kidron 2018 $436,310 $148,795 $522,569 $442,326 $1,550,000
Miriam Kidron 2020 $305,840 $70,000 $299,506 $13,354 $688,700
Miriam Kidron 2019 $267,386 $123,149 $211,128 $14,503 $616,166
Miriam Kidron 2018 $273,595 $46,614 $253,204 $13,643 $587,056
Avraham Gabay 2020 $130,554 $15,591 - $44,912 $191,418
Avraham Gabay 2019 $32,122 - $73,928 $9,441 $115,491
Joshua Hexter 2020 $190,801 $12,169 $351,128 $54,735 $608,833
Joshua Hexter 2019 $52,848 - - $9,022 $61,870
Joshua Hexter 2018 $161,002 $26,895 $269,196 $50,505 $507,598
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm

What are Oramed Pharmaceuticals Inc's Past Insider Trades?

Oramed Pharmaceuticals Inc's most recent insider trade came on March 16, 2023 by Nadav Kidron who bought 26,000 units worth $53.01K . In the last 15 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.78M and bought an estimated value of $6.59M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Nadav Kidron, President and CEO,  Miriam Kidron, Chief Scientific Officer,  and Leonard Sank, Director .

ORAMED PHARMACEUTICALS INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...